Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 18 results for "hariani company"

We hope bilateral pharmaceutical trade between the US and Indi...

The US-India Business Council (USIBC) led a Pharmaceutical & Biologics Executive Mission to Hyderabad and New Delhi late last month. Amy Hariani , Director, USIBC who manages the life sciences portfolio, reveals more in an interview with Shalini ... Financial Express, 1 week ago
Sify

Supreme Court bars Glenmark from selling Merck drug copies

The Supreme Court of India has barred Glenmark Pharmaceuticals from making and selling copies of U.S. drugmaker Merck's diabetes drugs Januvia and Janumet, according to a court document. The court has, however, allowed Glenmark to continue to sell ...
 Asia Legal Business1 week ago SC bars Glenmark from selling copies of Merck diabetes drugs  Livemint.com2 weeks ago UPDATE 1-Indian court bars Glenmark from selling Merck drug copies  Reuters UK2 weeks ago Indian court bars Glenmark from selling Merck drug copies  Channel NewsAsia2 weeks ago
[x]  
Business Times Singapore

S'pore still seen as major Asia Reit hub

Singapore INDIA and China are both developing frameworks for real estate investment trusts (Reits), but the threat to Singapore's position as a major regional Reit centre may be a distant one. Both have size in their favour, but there are ...
 Business Times Singapore1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less